Literature DB >> 32756879

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.

Melissa D Johnson1, Russell E Lewis2, Elizabeth S Dodds Ashley1, Luis Ostrosky-Zeichner3, Theoklis Zaoutis4, George R Thompson5, David R Andes6, Thomas J Walsh7, Peter G Pappas8, Oliver A Cornely9,10,11,12, John R Perfect1, Dimitrios P Kontoyiannis13.   

Abstract

In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world. However, the subject of antifungal stewardship (AFS) has received less attention. While the principles of AMS guidelines likely apply to stewarding of antifungal agents, there are additional considerations unique to AFS and the complex field of fungal infections that require specific recommendations. In this article, we review the literature on AMS best practices and discuss AFS through the lens of the global core elements of AMS. We offer recommendations for best practices in AFS based on a synthesis of this evidence by an interdisciplinary expert panel of members of the Mycoses Study Group Education and Research Consortium. We also discuss research directions in this rapidly evolving field. AFS is an emerging and important component of AMS, yet requires special considerations in certain areas such as expertise, education, interventions to optimize utilization, therapeutic drug monitoring, and data analysis and reporting.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antifungal; aspergillosis; candidiasis; diagnostics; guidelines; stewardship

Mesh:

Substances:

Year:  2020        PMID: 32756879      PMCID: PMC7403757          DOI: 10.1093/infdis/jiaa394

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  204 in total

1.  The economic impact of rapid Candida species identification by T2Candida among high-risk patients.

Authors:  Sara Pinar Bilir; Cheryl P Ferrufino; Michael A Pfaller; Julie Munakata
Journal:  Future Microbiol       Date:  2015-04-07       Impact factor: 3.165

Review 2.  Early diagnosis of invasive mould infections and disease.

Authors:  Frédéric Lamoth; Thierry Calandra
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

3.  Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.

Authors:  Michael J Dolton; John E Ray; Sharon C-A Chen; Kingsley Ng; Lisa Pont; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

Review 4.  PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.

Authors:  Tomer Avni; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

5.  Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

Authors:  Barbara D Alexander; Melissa D Johnson; Christopher D Pfeiffer; Cristina Jiménez-Ortigosa; Jelena Catania; Rachel Booker; Mariana Castanheira; Shawn A Messer; David S Perlin; Michael A Pfaller
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

6.  Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections.

Authors:  Emily L Heil; Lindsay M Daniels; Dustin M Long; Kyle G Rodino; David J Weber; Melissa B Miller
Journal:  Am J Health Syst Pharm       Date:  2012-11-01       Impact factor: 2.637

7.  The role of the multidisciplinary team in antifungal stewardship.

Authors:  Samir Agrawal; Rosemary Barnes; Roger J Brüggemann; Riina Rautemaa-Richardson; Adilia Warris
Journal:  J Antimicrob Chemother       Date:  2016-11       Impact factor: 5.790

8.  Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Authors:  Preeti Pancholi; Karen C Carroll; Donna M Wolk; Blake W Buchan; Raymond C Chan; Neelam Dhiman; Bradley Ford; Paul A Granato; Amanda T Harrington; Diana R Hernandez; Romney M Humphries; Matthew R Jindra; Nathan A Ledeboer; Shelley A Miller; A Brian Mochon; Margie A Morgan; Robin Patel; Paul C Schreckenberger; Paul D Stamper; Patricia J Simner; Nancy E Tucci; Cynthia Zimmerman
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

9.  Telemedicine infectious diseases consultations and clinical outcomes: a systematic review and meta-analysis protocol.

Authors:  Jason P Burnham; Stephanie A Fritz; Lauren H Yaeger; Graham A Colditz
Journal:  Syst Rev       Date:  2019-06-07

10.  Antimicrobial stewardship without infectious disease physician for patients with candidemia: A before and after study.

Authors:  Minoru Murakami; Hirokazu Komatsu; Masahide Sugiyama; Yuhei Ichikawa; Kyoko Ide; Rumi Tsuchiya; Kenji Kunieda; Akiko Magishi; Gaku Akiyama; Fumihide Miura; Kunihiko Okada; Masaya Ikezoe
Journal:  J Gen Fam Med       Date:  2018-02-20
View more
  16 in total

Review 1.  The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review.

Authors:  Arunaloke Chakrabarti; Naglaa Mohamed; Maria Rita Capparella; Andy Townsend; Anita H Sung; Renee Yura; Patricia Muñoz
Journal:  Open Forum Infect Dis       Date:  2022-05-11       Impact factor: 4.423

2.  Reply to Day et al.

Authors:  Melissa D Johnson; Russell E Lewis; Elizabeth S Dodds Ashley; John R Perfect; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2021-11-16       Impact factor: 5.226

3.  The Current State of Antifungal Stewardship in Immunocompromised Populations.

Authors:  William Alegria; Payal K Patel
Journal:  J Fungi (Basel)       Date:  2021-04-30

4.  A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study.

Authors:  Pavel Prusakov; Debra A Goff; Phillip S Wozniak; Azraa Cassim; Catherine E A Scipion; Soledad Urzúa; Andrea Ronchi; Lingkong Zeng; Oluwaseun Ladipo-Ajayi; Noelia Aviles-Otero; Chisom R Udeigwe-Okeke; Rimma Melamed; Rita C Silveira; Cinzia Auriti; Claudia Beltrán-Arroyave; Elena Zamora-Flores; Maria Sanchez-Codez; Eric S Donkor; Satu Kekomäki; Nicoletta Mainini; Rosalba Vivas Trochez; Jamalyn Casey; Juan M Graus; Mallory Muller; Sara Singh; Yvette Loeffen; María Eulalia Tamayo Pérez; Gloria Isabel Ferreyra; Victoria Lima-Rogel; Barbara Perrone; Giannina Izquierdo; María Cernada; Sylvia Stoffella; Sebastian Okwuchukwu Ekenze; Concepción de Alba-Romero; Chryssoula Tzialla; Jennifer T Pham; Kenichiro Hosoi; Magdalena Cecilia Calero Consuegra; Pasqua Betta; O Alvaro Hoyos; Emmanuel Roilides; Gabriela Naranjo-Zuñiga; Makoto Oshiro; Victor Garay; Vito Mondì; Danila Mazzeo; James A Stahl; Joseph B Cantey; Juan Gonzalo Mesa Monsalve; Erik Normann; Lindsay C Landgrave; Ali Mazouri; Claudia Alarcón Avila; Fiammetta Piersigilli; Monica Trujillo; Sonya Kolman; Verónica Delgado; Veronica Guzman; Mohamed Abdellatif; Luis Monterrosa; Lucia Gabriella Tina; Khalid Yunis; Marco Antonio Belzu Rodriguez; Nicole Le Saux; Valentina Leonardi; Alessandro Porta; Giuseppe Latorre; Hidehiko Nakanishi; Michal Meir; Paolo Manzoni; Ximena Norero; Angela Hoyos; Diana Arias; Rubén García Sánchez; Alexandra K Medoro; Pablo J Sánchez
Journal:  EClinicalMedicine       Date:  2021-01-29

5.  A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology.

Authors:  Nico A F Janssen; Roger J M Brüggemann; Monique H Reijers; Stefanie S V Henriet; Jaap Ten Oever; Quirijn de Mast; Yvonne Berk; Elizabeth A de Kort; Bart Jan Kullberg; Mihai G Netea; Jochem B Buil; Janette C Rahamat-Langendoen; Didi Bury; Eline W Muilwijk; Jacques F Meis; Paul E Verweij; Frank L van de Veerdonk
Journal:  J Fungi (Basel)       Date:  2020-11-10

Review 6.  Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

Authors:  Vasiliki Soulountsi; Theodoros Schizodimos; Serafeim Chrysovalantis Kotoulas
Journal:  Infection       Date:  2021-06-16       Impact factor: 3.553

7.  Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.

Authors:  Ali Amanati; Parisa Badiee; Hadis Jafarian; Fatemeh Ghasemi; Samane Nematolahi; Sezaneh Haghpanah; Seyedeh Sedigheh Hamzavi
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

Review 8.  T2Candida for the Diagnosis and Management of Invasive Candida Infections.

Authors:  Lea M Monday; Tommy Parraga Acosta; George Alangaden
Journal:  J Fungi (Basel)       Date:  2021-03-03

9.  Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study.

Authors:  Jannik Helweg-Larsen; Morten Steensen; Finn Møller Pedersen; Pia Bredahl Jensen; Michael Perch; Kirsten Møller; Birthe Riis Olesen; Mathias Søderlund; Maiken Cavling Arendrup
Journal:  J Fungi (Basel)       Date:  2021-12-06

10.  A retrospective 'real-world' cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosis.

Authors:  M Di Paolo; L Hewitt; E Nwanko; M Ni; A Vidal-Diaz; M C Fisher; D Armstrong-James; A Shah
Journal:  JAC Antimicrob Resist       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.